Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

被引：1
|
作者：
Yin, Zhao [1 ]
Zhang, Qing [1 ]
Ou, Ruiming [1 ]
Liu, Shuang [1 ]
机构：
[1] Guangdong Second Prov Gen Hosp, Dept Hematol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 25期
关键词：
D O I：
10.1200/JCO.24.00544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy
    Qiu, Lei
    Zhu, Feng
    Wei, Guoqing
    Wu, Wenjun
    Yang, Luxin
    Hu, Yongxian
    Huang, He
    REGENERATIVE THERAPY, 2020, 14 : 271 - 274
  • [22] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [23] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [24] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher J.
    Atrash, Shebli
    Khouri, Jack
    Voorhees, Peter M.
    Dima, Danai
    Simmons, Gary
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Arai, Sally
    Miklos, David B.
    Wagner, Charlotte B.
    Davis, James
    Sborov, Douglas W.
    Nishihori, Taiga
    Alsina, Melissa
    Locke, Frederick L.
    Gonzalez, Rebecca
    Kocoglu, M. Hakan
    Sannareddy, Aishwarya
    Afrough, Aimaz
    McGuirk, Joseph P.
    Shune, Leyla O.
    Patel, Krina
    Hansen, Doris K.
    BLOOD, 2022, 140 : 10377 - 10379
  • [25] Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma
    Ping Li
    Ningxin Dong
    Yu Zeng
    Jie Liu
    Xiaochen Tang
    Junbang Wang
    Wenjun Zhang
    Shiguang Ye
    Lili Zhou
    Alex Hongsheng Chang
    Aibin Liang
    Frontiers of Medicine, 2020, 14 : 811 - 815
  • [26] Chimeric antigen receptor T-cell therapy: a promising treatment modality for relapsed/refractory mantle cell lymphoma
    Li, Ping
    Dong, Ningxin
    Zeng, Yu
    Liu, Jie
    Tang, Xiaochen
    Wang, Junbang
    Zhang, Wenjun
    Ye, Shiguang
    Zhou, Lili
    Chang, Alex Hongsheng
    Liang, Aibin
    FRONTIERS OF MEDICINE, 2020, 14 (06) : 811 - 815
  • [27] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [28] Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
    Kirchberg, Janine
    Fischer, Luise
    Born, Patrick
    Brunner, Franziska
    Morgner, Charlotte
    Fuerst, Daniel
    Heyn, Simone
    Bach, Enrica
    Brueckner, Mandy
    Jentzsch, Madlen
    Wang, Song-Yau
    Boettcher, Sebastian
    Franke, Georg-Nikolaus
    Schrezenmeier, Hubert
    Platzbecker, Uwe
    Merz, Maximilian
    Vucinic, Vladan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e277 - e282
  • [29] Proposed clinical factors scoring system for chimeric antigen receptor T-cell (CAR T) patient selection in relapsed and refractory multiple myeloma (RRMM)
    Faiman, Beth
    Valent, Jason
    Khouri, Jack
    Williams, Louis
    Samaras, Christy J.
    Mazzoni, Sandy
    Sobecks, Ronald
    Scott, Cynthia
    Hamilton, Kimberly
    Schlueter, Kristen
    Sgobbo, Josephine
    Krieger, Katie
    Chiancone, Lisa
    Healy, Amy
    Cross, Kerry
    Ostrowski, Jennifer
    Coffman, Julie
    Hamilton, Betty
    Sauter, Craig
    Caimi, Paolo
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S39 - S40
  • [30] Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Dima, Danai
    Ahmed, Nausheen
    Dejarnette, Shaun
    McGuirk, Joseph
    Jia, Xuefei
    Raza, Shahzad
    Khouri, Jack
    Valent, Jason
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 298 - 305
12345